Apoptosis modulation as a promising target for treatment of systemic sclerosis

11Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Diffuse systemic sclerosis (SSc) is a fatal autoimmune disease characterized by an excessive ECM deposition inducing a loss of function of skin and internal organs. Apoptosis is a key mechanism involved in all the stages of the disease: vascular damage, immune dysfunction, and fibrosis. The purpose of this paper is to gather new findings in apoptosis related to SSc, to highlight relations between apoptosis and fibrosis, and to identify new therapeutic targets. Copyright © 2011 Stéphane Chabaud and Véronique J. Moulin.

Cite

CITATION STYLE

APA

Chabaud, S., & Moulin, V. J. (2011). Apoptosis modulation as a promising target for treatment of systemic sclerosis. International Journal of Rheumatology. https://doi.org/10.1155/2011/495792

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free